000 | 01735 a2200481 4500 | ||
---|---|---|---|
005 | 20250513211212.0 | ||
264 | 0 | _c20000721 | |
008 | 200007s 0 0 eng d | ||
022 | _a0300-9564 | ||
024 | 7 |
_a10.1007/s007020050004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade la Fuente-Fernández, R | |
245 | 0 | 0 |
_aEvidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations. _h[electronic resource] |
260 |
_bJournal of neural transmission (Vienna, Austria : 1996) _c2000 |
||
300 |
_a49-57 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
650 | 0 | 4 |
_aDihydroxyphenylalanine _xanalogs & derivatives |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorine Radioisotopes _xpharmacokinetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMotor Neurons _xmetabolism |
650 | 0 | 4 |
_aMovement Disorders _xdiagnostic imaging |
650 | 0 | 4 |
_aParkinson Disease _xdiagnostic imaging |
650 | 0 | 4 |
_aPresynaptic Terminals _xmetabolism |
650 | 0 | 4 |
_aSubstantia Nigra _xcytology |
650 | 0 | 4 | _aTomography, Emission-Computed |
700 | 1 | _aPal, P K | |
700 | 1 | _aVingerhoets, F J | |
700 | 1 | _aKishore, A | |
700 | 1 | _aSchulzer, M | |
700 | 1 | _aMak, E K | |
700 | 1 | _aRuth, T J | |
700 | 1 | _aSnow, B J | |
700 | 1 | _aCalne, D B | |
700 | 1 | _aStoessl, A J | |
773 | 0 |
_tJournal of neural transmission (Vienna, Austria : 1996) _gvol. 107 _gno. 1 _gp. 49-57 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s007020050004 _zAvailable from publisher's website |
999 |
_c10761252 _d10761252 |